This inventor holds 3 USPTO granted patents, plus 1 CIPO patent. Top assignees: Fit Biotech Oyj Plc, Fit Biotech Oy. Active years: 2009-2017.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2009-2017
Title: Marja Tähtinen - Innovator in HIV Treatment
Introduction
Marja Tähtinen is a notable inventor based in Tampere, Finland, recognized for her significant contributions in the field of medical innovation, particularly in treatments for HIV diseases. With a total of two patents to her name, she has leveraged her expertise to develop novel methodologies that advance therapeutic options for those in need.
Latest Patents
Tähtinen's latest patents focus on methods of treating HIV diseases utilizing innovative expression vectors. One patent details a therapeutic approach that involves administering a DNA vaccine composed of an expression vector along with a pharmaceutically acceptable excipient. This expression vector is designed with a heterologous promoter linked to a DNA sequence that encodes a nuclear-anchoring protein, which plays a crucial role in stimulating an immune response against the HIV virus. The second patent outlines further advancements in expression vectors, DNA vaccines, and gene therapeutics, emphasizing therapeutic applications and methodologies for their preparation.
Career Highlights
Throughout her career, Marja Tähtinen has worked with Fit Biotech Oyj Plc and Fit Biotech Oy, where she has contributed her innovative ideas to advance biotechnological solutions. Her research has been pivotal in the development of innovative therapies and she continues to impact the field significantly.
Collaborations
In her professional journey, Tähtinen has collaborated with esteemed coworkers such as Kai Krohn and Vesna Blazevic. These partnerships foster collaborative research and development efforts, enhancing the capability to innovate and push the boundaries of medical science.
Conclusion
Marja Tähtinen's work exemplifies the spirit of innovation in the medical field, particularly concerning HIV treatment. Her patents not only reflect her dedication to enhancing therapeutic methods but also showcase the potential for future advancements in biotechnology. As she continues her journey, the contributions of Tähtinen are likely to play a crucial role in shaping the future of treatments for infectious diseases.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile